AGK divergent transcript (AGK-DT)

AGK divergent transcript (AGK-DT) is classified as a long non-coding RNA (lncRNA) and is annotated in genomic databases as an RNA gene located in divergent orientation relative to the AGK protein-coding gene[5]. The term "divergent transcript" generally refers to a transcript arising from bidirectional transcription at promoters, usually resulting in antisense or noncoding RNA molecules positioned opposite to a nearby protein-coding gene[1]. Such transcripts are commonly observed throughout the genome and are often of uncertain biological function, with many serving as non-functional byproducts of transcriptional activity[1]. There is no evidence that AGK-DT encodes a protein or functions as a therapeutic target (such as a receptor, enzyme, or transporter). Additionally, there are currently no established disease associations, no known drugs targeting it, and it is not used as a biomarker[5]. The annotation "AGK divergent transcript" itself is likely a systematic name based on its position and relationship to AGK, rather than denoting a characterized molecule or actionable target. Divergent lncRNAs in general may be involved in regulation of gene expression, but specific function for AGK-DT is not described in published literature or gene function databases as of now[1][5]. Given the lack of functional, biochemical, or drug-relevant data, AGK-DT should not be considered a traditional therapeutic target, and its entry as a target entity is likely incorrect or misapplied[5].

Other names

AGK-DTAGK Divergent Transcript